
 
 
 
 
 
 
 
 
   
 1. A mutant replication control region having a nucleotide sequence as set forth in nucleotides 2478–3765 of SEQ ID NO:1 and having one point mutation independently selected from the group consisting of:
 a) a mutation of G to A at nucleotide 2490; 
 b) a mutation of C to Tat nucleotide 2496; 
 c) a mutation of T to C at nucleotide 2579; 
 d) a mutation by deletion of C at nucleotide 2633; 
 e) a mutation by deletion of C at nucleotide 2634; 
 f) a mutation of T to C at nucleotide 2663; 
 g) a mutation of A to G at nucleotide 2771; 
 h) a mutation of T to C at nucleotide 2805; 
 i) a mutation of C to A at nucleotide 2838; 
 j) a mutation of T to C at nucleotide 2914; 
 k) a mutation of T to C at nucleotide 2935; 
 l) a mutation of C to T at nucleotide 3003; 
 m) a mutation for substitution of G to A at nucleotide 3165; 
 n) a mutation of T to G at nucleotide 3262; 
 o) a mutation of C to T at nucleotide 3269; 
 p) a mutation of T to C at nucleotide 3344; 
 q) a mutation of C to T at nucleotide 3347; 
 r) a mutation for substitution of C to A at nucleotide 3456; 
 s) a mutation for substitution of T to C at nucleotide 3468; 
 t) a mutation for substitution of A to G at nucleotide 3570; 
 u) a mutation of T to C at nucleotide 3604; 
 v) a mutation of A to C at nucleotide 3641; 
 w) a mutation of A to G at nucleotide 3729; 
 x) a mutation of T to A at nucleotide 3739; and 
 y) a mutation of T to C at nucleotide 3747. 
 
 
     
 2. A mutant replication gene having the nucleotide sequence as set forth in SEQ ID NO:3 wherein:
 a) nucleotide position 117 is A; 
 b) nucleotide position 214 is G; 
 c) nucleotide position 221 is T; 
 d) nucleotide position 296 is C; 
 e) nucleotide position 299 is T; 
 f) nucleotide position 408 is A; 
 g) nucleotide position 420 is C; 
 h) nucleotide position 522 is G; 
 i) nucleotide position 556 is C; and 
 j) nucleotide position 593 is C. 
 
 
     
 3. A mutant replication gene as set forth as nucleotides 3049–3711 of SEQ ID NO:1 comprising one point mutation independently selected from the group consisting of:
 a) a mutation for substitution of G to A at nucleotide 117; 
 b) a mutation of T to G at nucleotide 214; 
 c) a mutation of C to T at nucleotide 221; 
 d) a mutation of T to C at nucleotide 296; 
 e) a mutation of C to T at nucleotide 299; 
 l) a mutation for substitution of G to A at nucleotide 408; 
 g) a mutation for substitution of T to C at nucleotide 420; 
 h) a mutation for substitution of A to G at nucleotide 522; 
 i) a mutation of T to C at nucleotide 556; and 
 j) a mutation of A to C at nucleotide 593. 
 
 
     
 4. A mutant replication control region selected from the group consisting of SEQ ID NOs:6, 8, 10, 12, 13, 14, 15, 17, 18, 20, and 21. 
 
     
 5. A plasmid comprising the mutant replication control region of either of  claim 1  or  4 . 
 
     
 6. A plasmid comprising the mutant replication gene of any one of  claims 2  or  3 . 
 
     
 7. The plasmid of  claim 5  wherein the plasmid replicates in a Gram-negative bacteria. 
 
     
 8. The plasmid of  claim 7  wherein the Gram-negative bacteria is selected from the group consisting of:  Acetobacter, Acinetobacter, Aeromonas, Agrobacterium, Alcaligenes, Anabaena, Azorizobium, Bartonella, Bordetella, Brucella, Burkholderia, Campylobacter, Caulobacter, Chromatium, Comamonas, Cytophaga, Deinococcus, Erwinia, Erythrobacter, Escherichia, Flavobacterium, Hyphomicrobium, Klebsiella, Methanobacterium, Methylbacterium, Methylobacillus, Methylobacter, Methylobacterium, Methylococcus, Methylocystis, Methylomicrobium, Methylomonas, Methylophilus, Methylosinus, Myxococcus, Pantoea, Paracoccus, Pseudomonas, Rhizobium, Rhodobacter, Salmonella, Shigella, Sphingomonas, Vibrio, Arthrobacter Bacillus, Methanomonas, Nocardia, Rhodopseudomonas, Xanthobacter, Bradyrhizobium,  and  Brevundimonas.    
 
     
 9. A Gram-negative host cell comprising a mutant replication control region according to either of  claim 1  or  4 . 
 
     
 10. The host cell according to  claim 9  selected from the group consisting of:  Acetobacter, Acinetobacter, Aeromonas, Agrobacterium, Alcaligenes, Anabaena, Azorizobium, Bartonella, Bordetella, Brucella, Burkholderia, Campylobacter, Caulobacter, Chromatium, Comamonas, Cytophaga, Deinococcus, Erwinia, Erythrobacter, Escherichia, Flavobacterium, Hyphomicrobium, Klebsiella, Methanobacterium, Methylbacterium, Methylobacillus, Methylobacter, Methylobacterium, Methylococcus, Methylocystis, Methylomicrobium, Methylomonas, Methylophilus, Methylosinus, Myxococcus, Pantoea, Paracoccus, Pseudomonas, Rhizobium, Rhodobacter, Salmonella, Shigella, Sphingomonas, Vibrio, Arthrobacter, Bacillus, Methanomonas, Nocardia, Rhodopseudomonas, Xanthobacter, Bradyrhizobium,  and  Brevundimonas.    
 
     
 11. A method for regulating gene expression in an organism comprising expressing at least one gene on a plasmid comprising the mutant replication control region of either of  claim 1  or  4  in an organism, such that gene expression is altered in the organism relative to expression of the at least one gene on a plasmid comprising the replication control region of pBBR1 in the organism. 
 
     
 12. The method of  claim 11 , wherein the gene expression is increased. 
 
     
 13. The method of  claim 12 , wherein:
 a) the at least one gene is selected from the group consisting of: crtM crtN crtN2, crtE crtX crtY, crtI, crtB, crtZ, crtW, crtO, crtA, crtC, crtD, crtF, and crtU; and 
 b) the organism is a C1 metabolizing bacteria. 
 
 
     
 14. The method of  claim 13  wherein the C1 metabolizing bacteria is selected from the group consisting of  Methylomonas, Methylobacter, Methylococcus, Methylosinus, Methylocyctis, Methylomicrobium,  and  Methanomonas.    
 
     
 15. A method according to  claim 14  wherein the C1 metabolizing host cell is a high growth methanotrophic bacterial strain, known as  Methylomonas  16a and having the ATCC designation PTA 2402. 
 
   
 
 
 
 
 
 
 
 
